🌏 Available in: English | 한국어

Hidden Heroes to Modern Medicine: The Mice Behind Medical Breakthroughs

Long before a new treatment reaches its first patient, the scientific journey often begins with a carefully designed mouse model.

⏱ In 30 Seconds

✓ Mouse models allow researchers to study how genes, cells and biological pathways contribute to disease inside a living organism.
✓ Mice share many genes and biological processes with humans, while their genomes can be precisely modified to test cause and effect.
✓ Knockout, transgenic, conditional, reporter, humanised and patient-derived tumour models are designed to answer different scientific questions.
✓ Mouse models have contributed to major advances in cancer biology, immunology, infectious disease, blood-cell development and genetic disease.
✓ Mice are not miniature humans, so findings from mouse models must ultimately be tested against human biology and clinical evidence.

Mouse models have played an important role in biomedical research for decades. Before a new treatment reaches clinical trials, researchers often need to understand how a disease develops in a living organism and whether a potential treatment can alter that process.

Cell culture is essential for studying molecular mechanisms, but cells grown in a dish cannot reproduce the full complexity of a living body. Blood circulation, metabolism, immune responses and interactions between different organs can all influence how a disease develops and how a treatment works.

This is where mouse models have been particularly useful. They allow researchers to study specific biological questions in a living system, while genetic technologies make it possible to alter individual genes, cell types or pathways in ways that cannot be tested directly in people.

Why Did Scientists Choose Mice?

Mice share many genes, cell types and biological pathways with humans, including fundamental processes involved in immunity, metabolism, blood-cell development and disease.

Their greatest experimental advantage is that their genes can be precisely modified. Researchers can remove, introduce or activate a gene in selected tissues and observe what happens inside a living organism — experiments that could never be performed directly in people.

This allows scientists to move beyond correlation and test cause and effect: Does this gene actually drive the disease? Does blocking this pathway change what happens?

A Mouse Model Is Not Just a Mouse

To someone outside a laboratory, research mice may all look similar. Scientifically, however, they can be profoundly different.

One mouse may lack a single gene. Another may carry a human cancer-associated mutation. A third may contain human immune cells, while another may carry tumour tissue obtained from a patient. Different strains also have different genetic backgrounds, immune responses and disease susceptibilities.

A mouse model is therefore not a miniature human or a universal copy of disease. It is a biological system designed to reproduce selected features of a particular condition and answer a clearly defined question.

Knockout Mice: What Happens When One Gene Is Missing?

A knockout mouse has been engineered so that a particular gene is absent or no longer functions normally. Scientists can observe what changes when that gene is lost and use those changes to determine what the gene normally does.

For example, if the removal of one gene prevents a particular immune-cell population from developing, that provides strong evidence that the gene is required for the development of that cell. If deleting a tumour-suppressor gene leads to cancer, it suggests that the gene normally helps protect cells from malignant transformation.

Some genes, however, are essential for embryonic development. This led to the development of conditional knockout mice, in which a gene can be removed only in a selected organ or cell population, or only after the animal reaches a particular age.

Transgenic Mice: Adding a Disease-Associated Gene

A transgenic mouse carries an introduced gene or has been engineered to produce unusually high levels of a particular protein. This allows scientists to observe how a disease-associated gene alters cells and tissues inside a living organism.

One well-known example from cancer research is the Eμ-Myc mouse. In this model, the MYC oncogene is overexpressed in the B-cell lineage, resulting in aggressive B-cell lymphoma.

Eμ-Myc mice have been used extensively to investigate how MYC drives cancer, how programmed cell-death pathways restrain tumour development and how different survival proteins influence treatment response. These studies contributed to the broader understanding of the BCL-2 family and the mechanisms through which cancer cells avoid apoptosis.

However, no single mouse model can represent the entire development of a medicine. A drug such as Venetoclax emerged from decades of work involving the discovery of BCL-2, studies of apoptosis, structural biology, medicinal chemistry, cancer cells, multiple animal models and clinical trials.

Mouse models formed one part of that much longer chain of evidence.

Conditional Models: Switching Genes On and Off at the Right Time

Many diseases do not begin at birth. Cancer, neurodegeneration and chronic inflammatory disease may emerge only after a mutation or molecular change occurs later in life.

Conditional mouse models allow genetic changes to be restricted to a particular cell type, organ or stage of life. Scientists can allow a mouse to develop normally and then activate an oncogene only in adult blood cells, or remove a gene from an established tumour to determine whether the tumour still depends on it.

These experiments have revealed an important principle: the genes required to initiate a disease are not always the same as the genes required to maintain it.

Reporter Mice: Making Invisible Biology Visible

A reporter mouse is engineered to produce a fluorescent or light-emitting signal when a particular gene is active or when a selected cell population is present.

These signals allow scientists to follow immune-cell migration, tumour growth, inflammation or stem-cell behaviour over time.

Humanised Mice: Bringing Human Immunity Closer to the Model

Mice and humans have important differences, particularly in their immune systems. Humanised mice help bridge this gap by introducing human blood-forming stem cells, immune cells or tissues into mice whose own immune systems have been weakened.

These models allow researchers to study aspects of human immunity, infection and cancer within a living organism. However, they still do not recreate a complete human immune system, because the human cells remain influenced by the mouse tissues, cytokines and metabolism around them.

Patient-Derived Xenografts: Growing a Patient’s Tumour in a Mouse

A patient-derived xenograft (PDX) is created by implanting tumour tissue from a patient into an immunodeficient mouse. These models can preserve some features of the original cancer and help researchers test experimental treatments, but they have important limitations: the mice lack a fully functioning immune system, tumours can change after transplantation, and not every patient tumour successfully grows.

Different Models Answer Different Questions

Knockout mouse — What happens when a particular gene is lost?
Transgenic mouse — Can an introduced gene produce or alter disease?
Conditional mouse — What does a gene do in one tissue or at one stage of life?
Reporter mouse — Where do selected cells travel, and when are particular genes activated?
Humanised mouse — How might human immune cells respond inside a living system?
PDX model — How might a patient-derived tumour respond to an experimental treatment?

How Mouse Models Helped Shape Modern Medicine

The influence of mouse research extends across almost every area of biomedical science. In cancer biology, mouse models have helped scientists investigate oncogenes, tumour suppressors, metastasis, programmed cell death, drug resistance and antitumour immunity.

In immunology, they have helped reveal the functions of T cells and B cells, antibody production, immune memory, self-tolerance, autoimmunity and transplant rejection. They have also contributed to research on infectious disease, blood-cell development, neurodegenerative disease and rare genetic disorders.

Modern treatments rarely emerge from a single decisive experiment. They are usually built through accumulated evidence from cell biology, mouse genetics, structural studies, patient samples and clinical trials.

Mouse models do not replace those other systems. They help connect them. They allow researchers to test whether a mechanism first observed in cells still operates within a living organism.

But a Mouse Is Not a Small Human

The value of mouse models should never be confused with perfection. Mice and humans differ in metabolism, immune responses, lifespan and physiology, and a therapy that works in mice may fail to produce the same benefit in people.

A result obtained in one mouse strain may also fail to reflect the genetic and clinical diversity found in human populations. The purpose of a mouse model is therefore not to reproduce every aspect of a human condition. It is to capture enough of the relevant biology to test a specific hypothesis.

This is why strong evidence rarely comes from one experimental system alone. Findings from mouse models can be compared with human cells, patient samples and ultimately clinical observations. When different approaches point towards the same conclusion, confidence in the result becomes much stronger.

A Personal Note

During my PhD, almost all of my experiments were done in vitro. I worked with cells and molecular pathways, but I had never performed a mouse experiment.

That changed with my first postdoctoral project, when I began working with a Wdr1 mutant mouse known as redears, which developed spontaneous autoinflammatory disease. For the first time, I could investigate how a molecular defect actually produced disease in a living organism.

We eventually found that the disease was driven by IL-18 rather than IL-1β, with monocytes and the pyrin inflammasome playing central roles. The work was published in the Journal of Experimental Medicine in 2015.

It was my first real experience of seeing how a mouse model could reveal biology that would have been very difficult to understand from cells alone.

Kim ML et al. Aberrant actin depolymerization triggers the pyrin inflammasome and autoinflammatory disease that is dependent on IL-18, not IL-1β. Journal of Experimental Medicine (2015).

Why This Story Still Matters

Most medical breakthroughs are remembered for the treatment that eventually reached patients, not for every experiment that came before it.

Mouse models have been part of that long process in many areas of medicine, from cancer and immunology to transplantation and infectious disease.

They are not perfect substitutes for human biology, and their use carries an ethical responsibility. But when a carefully designed mouse model answers a question that cannot yet be resolved in cells or patients, it can provide an important piece of evidence.

That contribution is often invisible, but it remains part of the history of modern medicine.

thebiostories

The Mice Behind Modern Medicine: The Hidden Heroes of Medical Breakthroughs